News from seqirus A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

17 Jul, 2019, 08:30 BST Anjana Narain to Lead Seqirus Influenza Vaccines Business

CSL Limited today named Anjana Narain, a seasoned leader in vaccines and biopharmaceuticals, as Executive Vice President and General Manager of its...


19 Oct, 2018, 13:23 BST Seqirus Cell-based Influenza Vaccine Nears European Approval

Seqirus, a global leader in influenza prevention, today announced that its cell-based quadrivalent influenza vaccine (QIVc) has received a positive...


26 Aug, 2016, 17:21 BST Seqirus presents analysis reinforcing the safety and immunogenicity profiles of its MF59®-adjuvanted seasonal trivalent influenza vaccine in adults 65 years and older

NOTE TO EDITORS: The influenza vaccines business, previously owned by Novartis, has been integrated into CSL's influenza vaccine business and now...


24 Aug, 2016, 13:22 BST Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for Young Children

NOTE TO EDITORS: On July 31, 2015 the CSL Group and its Affiliates acquired the influenza vaccines business of Novartis AG in the US. The influenza...


25 Apr, 2016, 13:00 BST Seqirus Commemorates 100 Years of Parent Company, CSL, Delivering on its Promise to Develop Innovative Therapies

Seqirus today commemorated with parent company, CSL Limited, 100 years of developing and delivering innovative therapies, including influenza...